X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2396) 2396
Publication (293) 293
Book Review (57) 57
Book Chapter (37) 37
Book / eBook (6) 6
Conference Proceeding (2) 2
Data Set (2) 2
Dissertation (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1745) 1745
index medicus (1449) 1449
oncology (1179) 1179
cancer (907) 907
female (821) 821
metastasis (645) 645
male (514) 514
animals (511) 511
middle aged (506) 506
chemotherapy (484) 484
metastatic melanoma (478) 478
aged (475) 475
care and treatment (393) 393
tumors (389) 389
breast cancer (387) 387
adult (384) 384
melanoma (380) 380
research (356) 356
medicine & public health (307) 307
metastatic breast-cancer (290) 290
metastatic colorectal-cancer (285) 285
cell line, tumor (267) 267
prognosis (253) 253
health aspects (249) 249
cell biology (245) 245
immunotherapy (244) 244
analysis (235) 235
treatment outcome (235) 235
antineoplastic agents - therapeutic use (232) 232
breast neoplasms - pathology (221) 221
neoplasm metastasis (218) 218
expression (217) 217
pharmacology & pharmacy (216) 216
mice (213) 213
aged, 80 and over (210) 210
development and progression (208) 208
article (201) 201
antineoplastic combined chemotherapy protocols - therapeutic use (193) 193
metastases (193) 193
pathology (191) 191
breast neoplasms - drug therapy (190) 190
mutation (190) 190
genetic aspects (188) 188
dermatology (183) 183
proteins (182) 182
metastatic breast cancer (178) 178
therapy (178) 178
cancer research (177) 177
antineoplastic agents - pharmacology (176) 176
cancer therapies (176) 176
immunohistochemistry (176) 176
survival (174) 174
cell lung-cancer (168) 168
drug therapy (168) 168
carcinoma (167) 167
neoplasms - drug therapy (167) 167
gene expression (166) 166
apoptosis (164) 164
review (162) 162
signal transduction (160) 160
breast-cancer (156) 156
biochemistry & molecular biology (154) 154
kinases (153) 153
clinical trials (150) 150
melanoma - pathology (146) 146
patients (144) 144
immunology (141) 141
colorectal cancer (139) 139
skin neoplasms - pathology (136) 136
disease progression (133) 133
medical research (132) 132
diagnosis (130) 130
medicine (130) 130
neoplasm staging (130) 130
disease-free survival (128) 128
phase-ii trial (128) 128
hematology, oncology and palliative medicine (126) 126
research article (126) 126
medicine, research & experimental (125) 125
phase-ii (125) 125
gene expression regulation, neoplastic (124) 124
monoclonal-antibody (123) 123
antineoplastic agents (121) 121
melanoma - drug therapy (121) 121
surgery (121) 121
growth-factor receptor (117) 117
skin cancer (117) 117
antimitotic agents (115) 115
breast neoplasms - metabolism (115) 115
neoplasms - pathology (115) 115
angiogenesis (110) 110
neoplasms (110) 110
metastatic (108) 108
stem cells (107) 107
cells (106) 106
medical prognosis (105) 105
risk factors (105) 105
epidermal growth factor (102) 102
oncology, experimental (102) 102
physiological aspects (102) 102
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2400) 2400
French (13) 13
German (8) 8
Spanish (6) 6
Korean (5) 5
Japanese (3) 3
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5
Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor shrinkage in more than 90% of patients with locally advanced basal cell... 
Dermatology | Basal Cell Carcinoma Outcomes with LDE225 Treatment study | hedgehog pathway inhibitor | sonidegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | advanced basal cell carcinoma | Locally advanced basal cell carcinoma | Advanced basal cell carcinoma | Metastatic basal cell carcinoma | Sonidegib | Hedgehog pathway inhibitor | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | MANAGEMENT | EFFICACY | GUIDELINES | OPEN-LABEL | DERMATOLOGY | DOSE-ESCALATION | UPDATE | INHIBITOR | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Biphenyl Compounds - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Biphenyl Compounds - therapeutic use | Young Adult | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Smoothened Receptor - antagonists & inhibitors | Pyridines - therapeutic use | Skin Neoplasms - pathology | Pyridines - administration & dosage | Double-Blind Method | Survival Rate | Disease Progression | Biphenyl Compounds - administration & dosage | Carcinoma, Basal Cell - drug therapy | Aged | Medical research | Care and treatment | Basal cell carcinoma | Analysis | Patient outcomes | Corn | Medicine, Experimental | Skin | Metastasis | Drug therapy | Cancer
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 72, Issue 6, pp. 1021 - 1026.e8
Journal Article
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. e755 - e764
The Hedgehog pathway inhibitors (HPIs), vismodegib and sonidegib, are increasingly employed in the treatment of patients with advanced basal cell carcinoma... 
Response | Recurrence | Basal cell carcinoma | Advanced | Sonidegib | Follow‐up | Metastatic | Vismodegib | MULTICENTER | MANAGEMENT | OPEN-LABEL | CHEMOTHERAPY | Follow-up | NONMELANOMA SKIN-CANCER | ONCOLOGY | HIGH-RISK | DOUBLE-BLIND | ADVERSE EVENTS
Journal Article
Journal Article
Journal Article
JAAD Case Reports, ISSN 2352-5126, 08/2018, Volume 4, Issue 7, pp. 678 - 681
Journal Article
Future Oncology, ISSN 1479-6694, 03/2018, Volume 14, Issue 6, pp. 515 - 525
Sonidegib, a hedgehog pathway inhibitor, was approved by the US FDA for the treatment of locally advanced basal cell carcinoma which cannot be readily treated... 
HPI | hedgehog pathway inhibitor | laBCC | sonidegib | mBCC | basal cell carcinoma | BOLT | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | LDE225 | PHASE-II | OPEN-LABEL | SMOOTHENED MUTATIONS | ONCOLOGY | DOUBLE-BLIND | SURGICAL EXCISION | INHIBITOR
Journal Article
Eplasty, ISSN 1937-5719, 2016, Volume 16, p. ic28
Journal Article
Current Dermatology Reports, ISSN 2162-4933, 12/2015, Volume 4, Issue 4, pp. 213 - 220
Journal Article
Journal of Nippon Medical School, ISSN 1345-4676, 2017, Volume 84, Issue 6, pp. 286 - 290
A 72-year-old man was referred to our hospital for treatment of an ulcer that had been growing on his back for 10 years. Physical examination showed an... 
lung metastasis | metastatic basal cell carcinoma | cisplatin | adriamycin | lymph node metastasis | Lymph node metastasis | Lung metastasis | Metastatic basal cell carcinoma | Adriamycin | Cisplatin | MEDICINE, GENERAL & INTERNAL | SKIN | CHEMOTHERAPY
Journal Article